Investment bank Piper Sandler has announced a downgrade of its investment rating for biopharmaceutical company Day One Biopharmaceuticals Inc. (stock code: DAWN) from "Overweight" to "Neutral".
Show original
At the same time, the institution lowered its target price from the previous $25 to $21.5. This adjustment reflects analysts' cautious assessment of the company's short-term outlook.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Bitdeer sold 163.1 BTC this week and currently maintains zero holdings.
Odaily星球日报•2026/03/07 04:36
A whale spent 12.5 million USDC to purchase 6,228 ETH 14 hours ago.
PANews•2026/03/07 04:29
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$68,038.49
-3.96%
Ethereum
ETH
$1,974.38
-4.80%
Tether USDt
USDT
$1.0000
-0.00%
BNB
BNB
$626.31
-3.36%
XRP
XRP
$1.36
-2.71%
USDC
USDC
$1.0000
+0.00%
Solana
SOL
$84.31
-4.65%
TRON
TRX
$0.2840
-0.52%
Dogecoin
DOGE
$0.09107
-2.68%
Cardano
ADA
$0.2584
-4.18%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now